Desq Long
Sign in

Company

Larimar Therapeutics, Inc.

LRMR · CIK 0001374690

SEC FORM 4
$0.00

Larimar Therapeutics, Inc. (LRMR)

Acquisition (code A) of 50,000 shares at $0.00 per share.

Reporting Person Harlow John B. Jr. · Officer Title President and COO · Transaction Code A

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001193125-26-410719 · filed 2026-10-01 · View filing →